Novel molecular markers for acute myeloid leukaemia disease activity

被引：0
|
作者：
Sittig, E. [1 ,2 ]
Kauko, O. [1 ,2 ,3 ,4 ]
Salmenniemi, U. [5 ]
Laiho, A. [1 ,2 ]
Kairisto, V. [6 ]
Johansson, J. [5 ]
Itala-Remes, M. [5 ]
Westermarck, J. [1 ,2 ,3 ]
机构：
[1] Univ Turku, Turku, Finland
[2] Abo Akad Univ, Turku Ctr Biotechnol, Turku, Finland
[3] Abo Akad Univ, Dept Pathol, Turku, Finland
[4] Abo Akad Univ, Turku Doctoral Programme Biomed Sci, Turku, Finland
[5] Turku Univ Hosp, Dept Med, FIN-20520 Turku, Finland
[6] Turku Univ Hosp, Cent Lab, FIN-20520 Turku, Finland
来源：
EUROPEAN JOURNAL OF CANCER | 2013年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3612
引用
收藏
页码：S840 / S840
页数：1
相关论文
共 50 条
  • [1] Molecular markers in acute myeloid leukaemia
    Andrea Kühnl
    David Grimwade
    International Journal of Hematology, 2012, 96 : 153 - 163
  • [2] Molecular markers in acute myeloid leukaemia
    Kuehnl, Andrea
    Grimwade, David
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2012, 96 (02) : 153 - 163
  • [3] Molecular genetics of acute myeloid leukaemia
    Dash, A
    Gilliland, DG
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2001, 14 (01) : 49 - 64
  • [4] Molecular therapy for acute myeloid leukaemia
    Coombs, Catherine C.
    Tallman, Martin S.
    Levine, Ross L.
    NATURE REVIEWS CLINICAL ONCOLOGY, 2016, 13 (05) : 305 - 318
  • [5] Molecular therapy for acute myeloid leukaemia
    Catherine C. Coombs
    Martin S. Tallman
    Ross L. Levine
    Nature Reviews Clinical Oncology, 2016, 13 : 305 - 318
  • [6] Applying molecular measurable residual disease testing in acute myeloid leukaemia
    Krigstein, Michael
    Iland, Harry J.
    Wei, Andrew H.
    PATHOLOGY, 2023, 55 (01) : 1 - 7
  • [7] Novel therapies for children with acute myeloid leukaemia
    A S Moore
    P R Kearns
    S Knapper
    A D J Pearson
    C M Zwaan
    Leukemia, 2013, 27 : 1451 - 1460
  • [8] Novel therapies for children with acute myeloid leukaemia
    Moore, A. S.
    Kearns, P. R.
    Knapper, S.
    Pearson, A. D. J.
    Zwaan, C. M.
    LEUKEMIA, 2013, 27 (07) : 1451 - 1460
  • [9] Preclinical activity of resazurin in acute myeloid leukaemia
    Ha, Trung Quang
    Andresen, Vibeke
    Erikstein, Bjarte Skoe
    Popa, Mihaela
    Gullaksen, Stein-Erik
    Reikvam, Hakon
    Mccormack, Emmet
    Gjertsen, Bjorn Tore
    BRITISH JOURNAL OF HAEMATOLOGY, 2024,
  • [10] The Impact of Novel Molecular Markers on Risk Stratification in Acute Myeloid Leukemia
    Lowenberg, Bob
    Valk, Peter
    Touw, Ivo P.
    Delwel, Ruud
    BLOOD, 2012, 120 (21)
12345